Dr. Yong Teng, PhD, is an associate professor of the Department of Hematology and Medical Oncology at Emory University, USA. He is the inaugural recipient of the Wally Award from Winship Cancer Institute of Emory University and a fellow of IAAM and VEBLEO. He is an active member of the International Head and Neck Scientific Group, the Royal Society of Medicine, American Association for Cancer Research, and other associations. One of his research interests lies in nanotechnology in cancer research and treatment. He has extensive experience in conducting investigator-initiated clinical trials and translational research. His team has authored over 100 articles and book chapters relating to cancer biology, nanotechnology, and nano-based drug delivery and genome editing, providing a balanced mix of basic and translational science to shed new light on cancer management and research. Dr. Teng has received several research awards from National Institutes of Health, Department of Defense, the industry, and other fund agencies. He also serves on a number of grant review panels, journal editorial boards, and international conference committees, demonstrating his exceptional commitment to serving the scientific community.
Title : The strategies and promise of nanoparticle based target therapeutics in head and neck cancer